Get the Stockscreener App
2.52
2.33%
-0.06
Vivos Therapeutics Inc stock is traded at $2.52, with a volume of 29,307.
It is down -2.33% in the last 24 hours and down -21.00% over the past month.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
See More
Previous Close:
$2.58
Open:
$2.55
24h Volume:
29,307
Relative Volume:
0.10
Market Cap:
$19.24M
Revenue:
$14.58M
Net Income/Loss:
$-12.57M
P/E Ratio:
-0.4437
EPS:
-5.68
Net Cash Flow:
$-13.07M
1W Performance:
-7.35%
1M Performance:
-21.00%
6M Performance:
-7.69%
1Y Performance:
-5.97%
1-Day Range:
$2.522
$2.57
1-Week Range:
$2.52
$2.88
52-Week Range:
$1.98
$7.95
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Name
Vivos Therapeutics Inc
Sector
Industry
Phone
(866)908-4867
Address
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
2.5636 | 19.36M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
122.74 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.61 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
357.13 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.27 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
80.68 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Vivos Therapeutics Inc Stock (VVOS) Latest News
Will Vivos Therapeutics Inc. see short term momentum2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
How to recover losses in Vivos Therapeutics Inc. stock2025 EndofYear Setup & Free High Return Stock Watch Alerts - newser.com
Vivos Therapeutics Inc. recovery potential after sell offJuly 2025 Big Picture & Reliable Entry Point Trade Alerts - newser.com
Best Momentum Stocks to Buy for January 8th - MSN
Forecasting Vivos Therapeutics Inc. price range with options dataTrade Performance Summary & Comprehensive Market Scan Reports - newser.com
Vivos Therapeutics Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Is Vivos Therapeutics Inc. stock undervalued vs historical averagesMarket Weekly Review & Target Return Focused Picks - newser.com
Is Vivos Therapeutics Inc. stock a safe haven assetWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
How supply chain issues affect Vivos Therapeutics Inc. stockBuy Signal & Growth Oriented Trade Recommendations - newser.com
How Vivos Therapeutics Inc. stock benefits from global expansion2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com
Study: Vivos Therapeutics Sleep Apnea Device Helps Improve Pediatric ADHD - Medical Product Outsourcing
What institutional flow reveals about Vivos Therapeutics Inc.Quarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Using Ichimoku Cloud for Vivos Therapeutics Inc. technicalsShare Buyback & Free Weekly Watchlist of Top Performers - newser.com
Vivos Therapeutics Inc. stock momentum explainedJuly 2025 Rallies & Safe Swing Trade Setup Alerts - newser.com
How risky is Vivos Therapeutics Inc. stock nowTrade Volume Report & Real-Time Volume Surge Alerts - newser.com
Using portfolio simulators with Vivos Therapeutics Inc. includedMarket Performance Recap & Verified Technical Trade Signals - newser.com
Can Vivos Therapeutics Inc. rally from current levelsJuly 2025 Rallies & Technical Pattern Alert System - newser.com
Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics - MarketScreener
Vivos (OTCQB: RDGL) and Exubrion expand collaboration on targeted radioisotopes - Stock Titan
Can Vivos Therapeutics Inc. stock surprise with earnings upsideCPI Data & Weekly Setup with High ROI Potential - newser.com
Vivos Therapeutics Inc Stock (VVOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):